MedTrace Logo

Atypical Antipsychotics in the Treatment of Affective Symptoms of Schizophrenia in Hungary

NCT01534936 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2153

Last updated 2012-12-20

No results posted yet for this study

Summary

This is a noninterventional observational study lead amongst psychiatrists, to assess the the overall status of schizophrenic outpatients with affective symptoms treated with atypical antipsychotics.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Attila Nemeth, MD PHD · National Center of Psychiatry

  • Lilla Szabo, MD · AstraZeneca

  • Alexandra Heringh, MD · AstraZeneca

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01534936 on ClinicalTrials.gov